Canaccord Genuity Downgrades GreenLight Biosciences (GRNA) to Hold
Tweet
Share
E-mailGet Alerts GRNA Hot Sheet
Price: $0.30 --0%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Join SI Premium – FREE
Canaccord Genuity analyst Bobby Burleson downgraded GreenLight Biosciences (NASDAQ: GRNA) from Buy to Hold with a price target of $0.30 (from $4.00).
For an analyst ratings summary and ratings history on GreenLight Biosciences click here. For more ratings news on GreenLight Biosciences click here.
Shares of GreenLight Biosciences closed at $0.29 yesterday.
You May Also Be Interested In
- JPMorgan Downgrades Amcor Plc. (AMCR) to Neutral
- ICICI Securities Downgrades Manappuram Finance Ltd (MGFL:IN) to Hold (3)
- Barclays Downgrades Murphy Oil Corp. (MUR) to Underweight
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
